Direct T-cell Presentation by cDC1: The Key Feature for Cancer Vaccine Success?
Sign Up to like & getrecommendations! Published in 2022 at "Cancer immunology research"
DOI: 10.1158/2326-6066.cir-22-0473
Abstract: In this issue of Cancer Immunology Research, Ferris and colleagues demonstrate that type 1 conventional DC (cDC1) vaccines drive tumor rejection through direct antigen presentation, without the need of endogenous cDC1. This suggests that cDC1-based… read more here.
Keywords: cdc1; cell presentation; direct cell; cancer ... See more keywords